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Available online xxxxMechanical loading is the primary functional determinant of bone mass and architecture, and osteocytes play a
key role in translating mechanical signals into (re)modelling responses. Although the precise mechanisms
remain unclear, Wnt signalling pathway components, and the anti-osteogenic canonical Wnt inhibitor Sost/
sclerostin in particular, play an important role in regulating bone's adaptive response to loading. Increases in
loading-engendered strains down-regulate osteocyte sclerostin expression,whereas reduced strains, as in disuse,
are associated with increased sclerostin production and bone loss. However, while sclerostin up-regulation
appears to be necessary for the loss of bone with disuse, the role of sclerostin in the osteogenic response to
loading is more complex. While mice unable to down-regulate sclerostin do not gain bone with loading, Sost
knockout mice have an enhanced osteogenic response to loading. The molecular mechanisms by which
osteocytes sense and transduce loading-related stimuli into changes in sclerostin expression remain unclear
but include several, potentially interlinked, signalling cascades involving periostin/integrin, prostaglandin,
estrogen receptor, calcium/NO and Igf signalling. Deciphering themechanisms bywhich changes in themechan-
ical environment regulate sclerostin production may lead to the development of therapeutic strategies that can
reverse the skeletal structural deterioration characteristic of disuse and age-related osteoporosis and enhance
bones' functional adaptation to loading. By enhancing the osteogenic potential of the context inwhich individual
therapies such as sclerostin antibodies act it may become possible to both prevent and reverse the age-related
skeletal structural deterioration characteristic of osteoporosis.
© 2016 Published by Elsevier Inc.1. Introduction
Mechanical loading is the primary functional determinant of bone
mass and architecture [1,2]. Loading generates strain (percentage
change in dimension) and other mechanically relevant stimuli (e.g.
ﬂuid ﬂow shear stress) throughout the bone tissue and within the
osteocyte canalicular network. Loading levels or distributions which
engender strains beyond a habitual minimum effective strain (MES)
trigger bone formation resulting in increased bone mass, improved
bone architecture and thus re-establishment of habitual levels and
distribution of strain [3–5]. Decreased loading, such as occurs during
disuse, results in osteoclastic bone resorption and bone loss in an appar-
ent attempt to also re-establish habitual levels and distribution of strain.
This homeostatic feedback loop, described by Harold Frost as ‘the
mechanostat’ [4], involves the site-speciﬁc co-ordinated (re)modelling
activity of osteocytes, osteoblasts and osteoclasts [5].Birth Defects, W2.02 2nd Floor,
titute of Child Health, UCL, 30
clerostin's role in bone's adapOsteocytes are embedded in the mineralised matrix and were long
thought to have little or no function, but are now known to play a
particularly important role in coordinating local bone remodelling
responses and have recently described as ‘master-regulators’ [6–8].
The Wnt antagonist Sost/sclerostin is almost exclusively expressed by
osteocytes in the adult skeleton [9], and osteocytes are also an impor-
tant source of receptor activator of nuclear factor κB ligand (Rankl)
[10], which probably plays a key role in initiating repair in damaged
bone; e.g. apoptosing osteocytes around microcracks secrete Rankl
[11]. Canonical Wnt signalling in osteocytes also regulates bone resorp-
tion via the expression of osteoprotogerin (Opg); mice lacking β-caten-
in in osteocytes have dramatically reduced bone mass due to reduced
Opg levels [12].
Given their location andmorphology, with long interlinked dendritic
processes forming a functional syncytium extending to the bone
surfaces, osteocytes are ideally suited to sense load-associated strains,
including shear strains across their membranes as ﬂuid is displaced
through their canalicular system. Osteocytes are now considered to be
the primary mechanosensors which locally coordinate adaptive (re)-
modelling responses [13]. The experiment by Skerry et al. [2] that led
us to acceptance of this hypothesiswas the demonstration of rapid strain
magnitude-related increases in the activity of the metabolism enzymetive response to mechanical loading, Bone (2016), http://dx.doi.org/
Fig. 2. Simpliﬁed model describing sclerostin's roles in bones' adaptation to loading-
engendered strains. Strains greater than the minimum effective strain (MES, green) are
association with low osteoclast activity and increased osteoblast activity, whereas the
low strains experienced in disuse are associated with reduced osteoblast activity and
increased osteoclast activity. The activity of these effector cells is coordinated by
osteocytes at least in part through sclerostin (red) secretion. In low strain conditions,
sclerostin inhibits osteoblast function and may indirectly promote resorption through
Rankl [73]. Strains greater than the MES down-regulate sclerostin, allowing activation of
osteoblasts at least in part through canonical Wnt signalling, which may indirectly
inhibit resorption through Opg expression. (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
2 G.L. Galea et al. / Bone xxx (2016) xxx–xxxglucose-6-phosphate dehydrogenase (G6PD) in osteocytes in the turkey
ulna following a short period of loading.
For many years after this, the mechanisms underlying the coordina-
tion of adaptive remodelling responses by osteocytes were largely
unknown. Hypothesised mechanisms included direct cell-cell commu-
nication [14,15] and/or the secretion of paracrine mediators such as
prostaglandins (PG) or insulin-like growth factors (Igf). However,
once sclerostin had been shown to be expressed in osteocytes [9],
Robling et al. [16] convincingly demonstrated that one potentially
important mechanism by which mechanical loading controls osteocyte
activity is by regulating sclerostin expression. His demonstration that
loading the mouse ulna down regulates sclerostin expression has been
reproduced in a variety of experimental loading models [17–23]
(Fig. 1). It then led to proposal of the simple model that local, loading-
related down-regulation of osteocyte sclerostin increases bone forma-
tion by relieving inhibition of canonical Wnt signalling in osteoblasts
while also, directly or indirectly through regulation of OPG, suppressing
the resorptive activity of osteoclasts (Fig. 2). The responses of transgenic
mice with altered sclerostin expression to changes in loading strongly
support the validity of this model. However, recent ﬁndings of
sclerostin-independent changes in bone formation following loading
[24] have demonstrated that this model is somewhat over-simpliﬁed.
Furthermore, the mechanisms by which loading-related stimuli initiate
this process by down-regulating sclerostin have only been partially
explored.
2. Loading-related changes in bonemass reﬂect sclerostin regulation
The model presented in Fig. 2 is largely based on the demonstration
that the cross-sectional distribution of strains engendered within load-
ing-responsive regions of mouse long bones spatially parallel the acute
down-regulation of sclerostin protein (within 24 h following an episode
of loading [18]) and subsequent increases in bone formation. As de-
scribed above, this was ﬁrst demonstrated in the mouse ulna subjected
to non-invasive axial loading [16]. Axial loading of the mouse ulna gen-
erates differentmagnitudes of mechanical strain in the bone's proximal,
middle and distal regions as well as in different cross-sectional sectors
at the same longitudinal site. Strainmagnitudes were found to correlate
with both the increase in bone formation and the down-regulation of
sclerostin within these regions. Conversely, the reduction in strain
experienced through tail suspension-induced disuse increased Sost
RNA expression in the mouse tibia. However, protein level analysis of
sclerostin expression by immunohistochemistry following tail suspen-
sion did not detect changes in the proportion of osteocytes stained
positive for sclerostin around the level of the tibia/ﬁbula junction [16].
The lack of change in sclerostin expression around the mouse tibia/
ﬁbula junction during tail suspension is potentially consistent with the
ﬁnding that this region appears to be the least affected by disuse, with
the most signiﬁcant bone loss occurring proximal and distal to thisFig. 1.Mechanical loading decreases, whereas disuse increases sclerostin expression. Sclerostin
cage activity, limbs subjected to disuse through sciatic neurectomy, and disused limbs subjected
et al. [19]. Scale bar = 50 μm.
Please cite this article as: G.L. Galea, et al., Sclerostin's role in bone's adap
10.1016/j.bone.2016.10.008region [25]. In a later study, Moustafa et al. [19] mapped site-speciﬁc
changes in sclerostin expression in themouse tibia using immunohisto-
chemistry following unilateral axial loading. In cross-sections from the
highly load-responsive proximal tibia, the increase in bone formation
and decrease in osteocyte sclerostin expression correlated with theme-
chanical strains predicted by ﬁnite element model analysis. In contrast,
in the distal tibia below the tibia/ﬁbula junction, sclerostin was not
down-regulated and bone formation did not increase following loading.
In the same study, disuse following sciatic neurectomy increased
sclerostin expression in both the proximal and distal tibia, and addition-
al loading after disuse signiﬁcantly reduced sclerostin expression in
both sites, although the magnitude of the effect was greater proximally.
Similar site speciﬁcitywas also observed in the trabecular compartment
of the proximal tibia: loading reduced sclerostin expression and
increased bone gain in the secondary spongiosa, but in the primary
spongiosa no bone formation was observed nor any associated down
regulation of sclerostin expression. These detailed analyses demon-
strate that the spatial distribution of bone loss with disuse and of bone
formation following loading closely follow the early changes in
sclerostin expression. However, none of the studies published to date
correlating changes in sclerostin expressionwith the spatial distribution
of bone formation ﬂowing loading have shown that the two are causallyimmunolocalisation in tibial cortical bone osteocytes of control limbs subjected to normal
to exogenous osteogenic axial loading. Figure reproducedwith permission fromMoustafa
tive response to mechanical loading, Bone (2016), http://dx.doi.org/
Fig. 3. Simpliﬁed schematic representation of transcriptional and epigenetic regulators of
basal Sost expression. In osteoblasts, the SOST gene is epigenetically repressed through
DNA methylation (M) and potentially histone acetylation (Ac). HDACs also ﬁne tune
SOST promoter and Mef2-dependant enhancer activity in cells which express Sost.
Transcriptional regulators able to bind the SOST promoter include osteoblast-speciﬁc
(Runx2, osterix) and non-bone-speciﬁc (MyoD, C/EBP) transcription factors. Once
expressed, Sost RNA stability is inﬂuenced by micro-RNAs including miR218.
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modelling is clearly complex as both continuous (catabolic) and inter-
mittent (anabolic) parathyroid hormone (PTH) treatments down-
regulate Sost despite having opposite effects on bone mass [26–28].
Evidence that the spatial correlation between loading-related
sclerostin regulation and changes in bone (re)modelling may be causal
is provided by loading studies using different genetically modiﬁed
mouse models. Sclerostin knockout mice do not show bone loss in re-
sponse to disuse induced by hind limb unloading [29] or botulinum
toxin injection [24], suggesting that sclerostin up-regulation is neces-
sary for disuse-induced bone loss. To determine whether sclerostin
down-regulation following increased loading is necessary for subse-
quent bone formation, transgenic mice harbouring the human SOST
gene driven by an 8 Kb Dmp1 promoter (SostTg) were generated [20].
Ulna axial loading down-regulates endogenous, but not human, Sost
expression in these mice. Further supporting evidence that sclerostin
down-regulation is required for loading-induced bone formation,
was the observation that loading induced signiﬁcantly greater bone
formation inwild type than SostTgmice. These independent studies spe-
ciﬁcally test the roles of sclerostin in bone's adaptation to loading and as
such provide strong evidence that both loading-related bone gain and
disuse-associated bone loss require changes in sclerostin expression,
at least in young mice.
Evidence supporting the potential importance of Sost down-regula-
tion in bones' osteogenic response to loading also comes from studies
utilising mice with genetic modiﬁcations in mechano-responsive path-
ways which result in altered Sost regulation following loading. For ex-
ample, increased basal sclerostin expression, abrogation of sclerostin
down-regulationwith loading and reduced load-related bone formation
is observed in periostin knockout (Postn−/−) mice [22]. Similarly, four
point tibial bending of mice lacking osteocytic Igf1 expression does
not result in Sost down-regulation and triggers a diminished osteogenic
response to loading compared with wild type controls [23]. In contrast,
deletion of the androgen receptor in male androgen receptor (AR)
knockout mice is associated with greater sclerostin down-regulation
and enhanced bone formation following loading compared with wild
type controls [21]. Taken together, these studies provide examples of
situations in which changes in sclerostin regulation are associated
with altered adaptive responses to loading.
3. Mechanisms underlying sclerostin down-regulation by loading
The above in vivo studies describing altered basal sclerostin expres-
sion and changes in the load-related regulation of sclerostin in geneti-
cally modiﬁed mice, while informative, provide limited insight into
the molecular mechanisms by which osteocytes regulate sclerostin ex-
pression. Instead in vitro studies using a variety of model systems have
been required to address this. These studies have shown that the basal
rate of sclerostin expression is under both transcriptional and broader
epigenetic control (Fig. 3). Its restricted expression in osteocytes is
achieved through an epigenetic mechanism; the SOST promoter is
DNA methylated in osteoblasts but becomes demethylated during the
osteoblast to osteocyte transition, allowing initiation of gene expression
[30]. Transcription factors known to bind elements in the demethylated
SOST promoter include the bone-speciﬁc transcription factors Runx2
and Osterix [31,32]. Bone non-speciﬁc transcription factors such as
MyoD and C/EBP also bind the SOST promoter in human Saos-2 cells
[31]. The ability of these various factors to regulate Sost expression is
epigenetically determined by histone deacetylase (HDAC) enzymes
such as Sirt1 and HDAC5 [33,34], and once expressed Sost RNA stability
is inﬂuenced by micro-RNAs such as miR-218 [35].
SOST promoter activity is enhanced by Mef2 binding to a distal en-
hancer element and inhibition of this binding is one of the mechanisms
bywhich Sost is down-regulated by PTH [34,36,37]. Similarmechanistic
studies into Sost regulation by strain have been hindered by the limited
availability of cellular models. Primary osteoblasts do not expressPlease cite this article as: G.L. Galea, et al., Sclerostin's role in bone's adap
10.1016/j.bone.2016.10.008readily detectable levels of Sost until they form mineralised matrix,
which precludes their use for in vitro strain studies. Mouse osteocytic
MLO cell lines do not reliably produce readily detectable levels of Sost
[38] and their expression of the constitutively active SV40 antigen [39]
impacts PI3K/AKT signalling, which is a stain-responsive pathway [40].
Themore recently developed IDG-SW3 cell line promises to circumvent
this limitation, but these cells only express Sost after prolonged periods
of differentiation [41]. Not surprisingly few osteoblastic cell lines
express detectable Sost. However, rat UMR-106 osteosarcoma cells do
respond to strain [40] and express very high levels of Sost in a manner
akin to them having a constitutively active gene [38], but this makes
the physiological relevance of this model questionable. In contrast,
human Saos-2 osteosarcoma cells are also mechanoresponsive, but
only conﬂuent cultures express readily detectable Sost RNA and
sclerostin protein [41–43] which is why we have used this model
system. Subjecting subconﬂuent cultures of Saos-2 cells to in vitro strain
by four point bending increases their proliferation [43,44], whereas
conﬂuent cultures up-regulate osteocalcin and down-regulate Sost
over a time course which parallels that seen in rodent bones following
in vivomechanical loading [43,45].
Using the Saos-2 model we initially reported that Sost down-regula-
tion by strain involves Cox2-initiated PGE2 signalling through an EP4/
ERK pathway [45], consistent with a previous report that selective
treatment with an EP4 agonist enhances the osteogenic responses to
mechanical loading in vivo [46]. The importance of this pathway in the
mechanical regulation of Sost expression is further demonstrated by
the recent report that Cox inhibition with carprofen prevents sclerostin
down-regulation in the ulnae of mice subjected to axial loading [47].
Cox2 upregulation in mechanically-stimulated osteoblastic cells is
abrogated by inhibition of nitric oxide (NO)/protein kinase G (PKG)
signalling down-stream of calcium signalling [48]. Inhibition of the NO
synthase (Nos) enzyme also abrogates ﬂuid shear-induced Sost down-
regulation in osteoblastic cells [49], whereas long bone derived osteo-
blastic cells from AR knockout mice, which show enhanced sclerostin
down-regulation in vivo, produced higher levels of NO when subjected
to ﬂuid shear in vitro [21].
AR, NO and PGE2 signalling pathways are all inﬂuenced by estrogen
receptors (ERs), which also interact with canonical Wnt pathway com-
ponents in mechanically strained osteoblastic cells [50,51]. Our group
and others have shown that the ERs, particularly ERα, are mediatorstive response to mechanical loading, Bone (2016), http://dx.doi.org/
Fig. 4. Schematic representation of pathways implicated in sclerostin down-regulation by
mechanical stimulation. (1) Strain rapidly activates Ca signalling and down-stream (2)
NO/guanylate cyclase (GC)/PKG signalling leading to up-regulation of Cox2, which also
involves ERβ. Cox2 produces PGE2 (3) which is released at least in part through Cx43
hemichannels to activate EP receptors including EP4. EP4 activates ERK (4) signalling.
Strain-induced ERK activation also involves ERβ and ER transcriptional activity is in turn
increased in osteoblastic cells by PGE2. Activated ERβ can up-regulate periostin (Postn)
expression (5). Periostin acts through integrins (6) including integrin αV, which
interacts with the Igf1 receptor (7). Responses down-stream of Igf1R include ERα-
mediated activation of AKT (8), however, the mechanisms by which the signalling
cascades described inhibit Sost expression following exposure to strain remain unknown.
4 G.L. Galea et al. / Bone xxx (2016) xxx–xxxof bone's adaption to loading (as reviewed in [50]). Global deletion of
ERα greatly diminishes cortical osteogenic responses to loading [52]
thus we were surprised to observe that blockade of ERα does not
prevent Sost down-regulation by strain in Saos-2 cells, rather ERα inhi-
bition in vitro or global deletion in vivo reduces basal Sost levels [43].
However, this observation is consistent with the subsequent demon-
stration that deletion of ERα in mature osteoblasts and osteocytes
does not impair the adaptive response to axial tibial loading in female
mice [53,54]. In contrast, ERβ blockade does not alter basal Sost levels,
but prevents strain-induced Sost down-regulation in Saos-2 cells [43].
Although the role of ERβ in bone's adaptation to loading has not been
extensively investigated, it is worth noting that ERβ enhances Cox2
up-regulation [55] and ERK activation [56] following mechanical
stimulation in different in vitromodels.
Both these roles of ERβ are consistent with a down-stream Cox-2/
PGE2/ERK pathway mediating Sost down-regulation following strain,
although ERβ may also act down-stream of PGE2 signalling as PGE2
treatment increases estrogen response element activation in osteoblas-
tic cells [57]. Interestingly ERβ knockdown prevents periostin up-regu-
lation by estradiol in periodontal ligament cells [58] and given periostin
knockoutmice do not show signiﬁcant sclerostin down-regulation [22],
ERβ's role in sclerostin regulation may be through periostin as well as
through ERK activation. Activation of ERK could be either up-stream of
periostin action and/or down-streamof its binding to integrin receptors,
including integrin αV [3,59,60] and deletion of integrin αV in the
osteoblast lineage prevents Sost down-regulation in the ulnae of mice
subjected to axial loading [61]. Integrin αV directly interacts with and
facilitates Igf1/Igf1R signalling [62,63], which is potentially consistent
with the report that osteocyte Igf1 deletion also abrogates loading-
induced Sost down-regulation [23]. Intriguingly, integrin αV also facili-
tates opening of connexin (Cx)43 hemichannels and Cx43 facilitates
the release of PGE2,which is involved in the rapid activation of β-caten-
in in osteoblastic cells subjected to mechanical stimulation in vitro [64,
65]. However, integrin αV expression is not required for ERK activation
in calvarial osteoblastic cells subjected to ﬂuid shear [61].
To date, no in vivo studies have been published that have systemat-
ically investigated the roles of different mechano-responsive signalling
pathways in sclerostin regulation following loading. The majority of
available studies are based on in vitro observations in osteoblastic cell
lines subjected to deﬁned mechanical stimuli which cannot fully repli-
cate the effects of in vivo loading on the heterogeneous cell populations
residing in and on bone. Currently, only Cox2/prostaglandin signalling
has been demonstrated to acutely regulate sclerostin expression in
vitro, suggesting a direct effect, and to also facilitate sclerostin down-
regulation following loading in vivo. Furthermore, the mechanisms by
which unloading results in sclerostin up-regulation have not been
investigated and cannot be assumed to be the same as those which re-
sult in its down-regulation following increased loading. Nonetheless,
putting the available jigsaw pieces together it is possible to propose a
linear pathway which links early strain-related signalling events to
ultimate down-regulation of Sost expression (Fig. 4). The sequence of
events proposed in Fig. 4 is potentially consistent with the timing of
gene expression changes seen following loading; Cox2 is up-regulated
within 1–2 h [66] followed by Postn up-regulation around 6 h [22] and
eventually Sost down-regulation 8–24 h after loading [47,67]. However,
the direct mechanisms by which loading-related stimuli decrease Sost
promoter activity and/or reduce Sost RNA stability remain unknown
andmerit further study. The proposedmodel is also limited in assuming
that all of the reported mediators of Sost down-regulation are involved
in osteocytes' acute and immediate responses to strain. Bones' ability to
respond to acute changes in loading is context dependent and multiple
factors, local and systemic, are likely to inﬂuence the way Sost expres-
sion is regulated by loading; e.g. in a bone which has adapted its mass
and architecture to the customary loads placed upon it, osteocytes
and/or adjacent osteoblasts are likely to express factors which may
limit or enhance strain-related Sost down-regulation.Please cite this article as: G.L. Galea, et al., Sclerostin's role in bone's adap
10.1016/j.bone.2016.10.0084. Sclerostin itself inﬂuences the osteogenic context in which
loading acts
Sclerostin itself is one such modulator of the osteogenic context; e.g.
in vitro, its presence inhibits recruitment of Saos-2 cells to the cell cycle
following mechanical strain or Wnt3a treatment, but not following
treatment with estradiol [43,44]. Sclerostin has also been shown to re-
duce proliferation and increase apoptosis in the absence of mechanical
stimulation in other models [68,69]. In addition, sclerostin has the po-
tential to inﬂuence multiple signalling pathways that regulate various
stages of the osteoblast lineage. Reported effects of sclerostin treatment
on osteoblastic cells in vitro include inhibition of differentiation [70–72],
inhibition of mineralisation [71], induction of RANKL expression [73],
and promotion of osteocytic osteolysis [74]. Short term treatment of os-
teoblastic cells with recombinant sclerostin alters (predominantly
down-regulates) the expression of a large number of genes, many of
which are components of the Wnt signalling pathway [75]. This is
consistent with sclerostin acting primarily as a canonicalWnt signalling
inhibitor, although potential interactionswith BMP and platelet derived
growth factor (PDGF) cascades have also been reported [9,72]. In the
context of bone's response to loading, transgenic mice deﬁcient for
canonical Wnt co-receptors or the intra-cellular secondary signalling
molecule β-catenin show diminished responses to mechanical loading
[47,76,77]. β-Catenin is rapidly activated in osteocytes subjected tome-
chanical loading, but this response is diminished in osteocytes of mice
unable to down-regulate sclerostin [20]. Taken together, these studies
provide strong evidence that sclerostin acts as a canonicalWnt pathway
inhibitor and that its down-regulation facilitates activation of this path-
way following loading, but whether sclerostin directly or indirectly
modulates other pathways following loading remains unknown.
5. Sclerostin down-regulation is not sufﬁcient for load-related
osteogenesis
The ﬁndings discussed thus far suggest that altered sclerostin
expression is a critical osteocyte response to changes in mechanical
loading and that sclerostin regulation permits/facilitates both adaptive
osteogenesis when loads are increased and net resorption when theytive response to mechanical loading, Bone (2016), http://dx.doi.org/
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sclerostin, are important for mediating bone's adaptive responses, it is
wrong to assume that bone's responses to disuse and loading are
regulated by the same mechanisms. This was suggested several years
ago by a microarray study which showed that the genes and pathways
regulated by loading are not all the same as those regulated by disuse
[67]. Putting it another way; just because a cell or signalling pathway
plays a critical role in the context of disuse, it does not mean that it
will also be as important in regulating the bone formation response
following loading. This is illustrated in an experiment which targeted
ablation of osteocytes using diphtheria toxin [78]. Osteocyte ablated
mice do not lose bone during unloading induced by tail suspension,
however, osteocyte ablation does not prevent bone restoration caused
by return to normal activity following a period of disuse. This suggests
that either tail suspension induces bone loss throughmechanisms unre-
lated to loading, such as increased glucocorticoid production [79], or
that the responses of other cells to changes in loading are sufﬁcient for
normal bone gain following loading in the absence of osteocytes (and
therefore sclerostin).
This latter interpretation is consistent with the recent report that
Sost knockout mice do not lose bone due to unloading, but still show
osteogenic responses to increased loading [24]. In fact, when loaded so
as to generate equivalent strains, Sost−/−mice show greater bone for-
mation than wild-type controls. Thus, while viable osteocytes able to
up-regulate sclerostin expression appear to be an absolute requirement
for bone loss in disuse, down-regulation of sclerostin following loading
does not appear to be so critical for the subsequent osteogenic response.
That osteocytes are not the only cell involved in the adaptive response
to loading should not come as a surprise given that numerous studies
have shown that osteoblast-like cells are also mechano-sensitive.
Well-established responses of osteoblast-like cells to strain include
enhanced osteoblastic differentiation of marrow stromal cells (MSCs)
as well as resumption of proliferation of cortical long bone derived
osteoblastic cells [44,52,80–82]. Furthermore, the study which, to the
authors' knowledge, was the ﬁrst to demonstrate that osteocytes
respond rapidly to changes in mechanical loading showed equally
rapid responses (within 6 min) in adjacent periosteal cells [2].
The ability of osteoblasts to sense and respond to strain in vitro is
clearly demonstrated by their ability to very rapidly enter into the cell
cycle after strain exposure in the absence of sclerostin [18,43,44,52]. In
vivo, an increase in the number of osteoblasts on the periosteal surface
is seen within 24 h following loading [18], although the location and
nature of the proliferative osteoblast population remains undeﬁned. A
recent study on the effect of age on the loading response provides fur-
ther evidence that down-regulation of sclerostin in osteocytes does
not necessarily translate into an appropriate bone formation response.
We hypothesised that in old mice loading would not down regulate
sclerostin, but instead found that loading down-regulated sclerostin in
19-month-old mice to the same extent as in young (17-week-old)
mice [18], even though the osteogenic response to non-invasive axial
tibial loading was lower in old than in young animals. Interestingly
this study showed that in old mice it was the ability of osteoblasts to
proliferate that was compromised; osteoblast progression through the
cell cycle following strain exposure in vitro and the increase in the num-
ber of periosteal osteoblasts following loading in vivo were impaired.
These deﬁciencies in osteoblast function that occur with age may not
only limit bone's adaptive responses to loading but also the beneﬁcial
effect of sclerostin neutralising therapies [83].
The ﬁnding that osteocytes in tibiae of oldmice remain able to sense
changes inmechanical loading and acutely respond by down-regulating
Sost has recently been independently replicated byHolguin et al. [84]. In
the Holguin study, a single bout of axial tibial loading effectively down-
regulated Sost in 5-month-old as well as 12-month-old and 22-month-
old mice, although the bone formation response was blunted with age.
A possible explanation is that Sost RNA down-regulation is more
transient in bones from 22-month-old than 5-month-old mice andPlease cite this article as: G.L. Galea, et al., Sclerostin's role in bone's adap
10.1016/j.bone.2016.10.008others have shown changes in Wnt pathway-related gene transcripts
and blunting of β-catenin activity in the old [84–86]. Intriguingly,
Holguin et al. found that while repeated bouts of loading on subsequent
days repeatedly down-regulate Sost in youngmice, only the ﬁrst bout of
loading results in Sost down-regulation in the old. This suggests that old
bone cells become refractory to repeated bouts of increased loading.
However, we have recently reported that prior and concurrent disuse
enhances the osteogenic response to repeated bouts of axial tibial
loading in aged mice [87]. Whether this “rescue” of bone's response to
loading in old mice is associated with the restoration of cells' ability to
down-regulate sclerostin after each bout of loading needs to be deter-
mined. Nonetheless these studies demonstrate bone's “strain memory”
inﬂuences subsequent responsiveness and that this relationship
becomes less effective in the elderly. The relevance of these ﬁndings
from rodent studies to elderly humans remains to be established.
6. Conclusions
Numerous studies have demonstrated that sclerostin plays a role in
the effective working of the mechanisms associated with regulation of
bone mass and architecture in relation to mechanical loading (the
mechanostat). Sclerostin expression increases following unloading
with the consequent inhibition of Wnt signalling and associated bone
loss. Down-regulation of sclerostin is permissive for osteogenesis in
response to loading, at least in part by relieving inhibition of canonical
Wnt signalling. This is consistent with the potently osteogenic
responses observed in humans treated with sclerostin-inhibiting anti-
bodies now in advanced stages of clinical development [88]. However,
sclerostin down-regulation in osteocytes is not the only process linking
cellular mechanically related responses to functional remodelling as
evidenced bymice lacking Sost having an enhanced response to loading.
This is consistent with the emerging narrative that there is not a single
linear pathway regulating bone's adaptive responses to loading, rather
multiple pathways in which osteoblasts as well as osteocytes play im-
portant roles [50,89,90]. Elucidating the complex cellular mechanisms
involved in mechano-responsiveness remains important because it
could lead to the development of ‘smart’ novel therapeutic targets
able to augment bones' speciﬁc physiological adaptive responses to
loading-engendered stimuli rather than relying on non-speciﬁc, and
largely ineffective, therapies to prevent or reverse loss of bone mass.
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